Applied uv and 3sixty biopharmaceuticals sign exclusive distribution agreement for airocide(r) air purification systems for the continent of africa

$3.5 million minimum first year purchase commitment of airocide ® systems mount vernon, ny / accesswire / may 19, 2021 / applied uv, inc. (nasdaq:auvi) ("applied uv" or the "company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("uvc") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced the signing of an exclusive distribution agreement with 3sixty biopharmaceuticals (pty) ltd. ("3sixty") for the distribution of the airocide® consumer and commercial air purification systems within the continent of africa.
AUVI Ratings Summary
AUVI Quant Ranking